Overview
Expressing Takeda in Numbers
Corporate Philosophy
Message from Top Management
Mid-Range Growth Strategy
Our Management
Compliance
Crisis Management
Business Activities
Worldwide
History
Takeda Channel
Overview
IR Calendar
Financial Highlights
Quarterly Results / Presentations
Fundamental Policy
Annual Reports
Stock Information / Rating
Profit Distribution
Shareholders' Meeting
Disclaimer
CSR in Takeda
Support for Areas Affected by the Great East Japan Earthquake
CSR Activities and Targets
ISO 26000 Core Subjects
Organizational Governance
Human Rights
Labor Practices
The Environment
Fair Operating Practices
Consumer Issues
Community Involvement and Development
Policies
Reports
CSR Data Book Survey
R&D in Takeda
Message from R&D Leaders
R&D Pipeline
Drug Discovery Processes
R&D Organizations
Clinical Trial Register
Research Alliances
Intellectual Property
Publications of Takeda Research Laboratories
Investigator Initiated Sponsored Research
Partnering with Takeda
Partnership Opportunities Sought
A Track Record of Successful Collaborations
Business Development Organization
Contacts
Job Offers
Latest News Release
2013
2012
2011
2010
2009
>
Sitemap
Sitemap
PRODUCTS
Core Products
INVESTORS
Overview
IR Calendar
Financial Highlights
Segment Information
Sales of Major Products
Quarterly Results / Presentations
Latest Quarterly Results / Presentations
FY 2012
FY 2011
FY 2010
FY 2009
FY 2008
FY 2007
Fundamental Policy
Annual Reports
Stock Information / Rating
Profit Distribution
Shareholders' Meeting
Disclaimer
NEWSROOM
Latest News Release
2012
2011
2010
2009
2008
CAREERS
Job Offers
R&D
R&D in Takeda
Message from R&D Leaders
Message from Tadataka Yamada, M.D. Director and Chief Medical & Scientific Officer
Message from Deborah Dunsire, M.D. President & CEO of Millennium Pharmaceuticals, Inc.
Message from Section Leaders
R&D Pipeline
Drug Discovery Processes
R&D Organizations
Shonan Research Center
Millennium Pharmaceuticals, Inc.
Takeda Shanghai Development Center
CMC Center
Takeda Global Research & Development Center (Asia) Pte.Ltd.
Takeda Global Research & Development Centre (Europe) Ltd.
Takeda Global Research & Development Center, Inc.
Clinical Trial Register
Clinical Study Protocol Summaries
Clinical Study Report Summaries
Research Alliances
Intellectual Property
Publications of Takeda Research Laboratories
Investigator Initiated Sponsored Research
ABOUT TAKEDA
Overview
Expressing Takeda in Numbers
Corporate Philosophy
Message from Top Management
Mid-Range Growth Strategy
Our Management
Biographies of Board Members and Corporate Auditors
Compliance
Crisis Management
Business Activities
Worldwide
History
1781-1944
1945-1984
1985-1999
2000-
Takeda Channel
Worldwide
Worlwide
Japan
Japan
PARTNERSHIP
Partnering with Takeda
Partnership Opportunities Sought
A Track Record of Successful Collaborations
Business Development Organization
Contacts
Contact
FAQ
Contact
Terms of Use
Terms and Conditions of Use
Technical Details
Takeda.com RSS Feeds
Accessibility
Accessibility
Privacy Policy
Privacy Policy
RESPONSIBILITY
CSR in Takeda
Principles: United Nations Global Compact
Implementation: ISO 26000
Disclosure: IIRC
Dialogue: AA1000
Support for Areas Affected by disasters
Support for Japan's Vitality and Recovery
Long-Term Ongoing Support
Supporting Employees' Volunteer Activities
Takeda Life and Livelihood Reconstruction Program
CSR Activities and Targets
CSR Activity Targets and Results
CSR Activity Targets for Fiscal 2012
ISO 26000 Core Subjects
Organizational Governance
Measures to Create Corporate Value
CSR Management
Due Diligence
Stakeholder Engagement
Future Outlook
Human Rights
Measures to Create Corporate Value
Issues and Initiatives (Research/Development)
Issues and Initiatives (Other Areas)
Future Outlook
Labor Practices
Measures to Create Corporate Value
Global Human Resources Policy
Promoting Diversity
Work-Life Balance/ Workers Unions
Future Outlook
The Environment
Measures to Create Corporate Value
Environmental Management
Reducing Environmental Risks
Initiatives to Deal with Climate Change
Water Resources/Biodiversity
Future Outlook
Fair Operating Practices
Measures to Create Corporate Value
Toward Fair Operating Practices
Initiatives in the Industry
Global CSR Purchasing/Guidelines
Future Outlook
Consumer Issues
Measures to Create Corporate Value
Anti-Counterfeit Measures
Strengthening Value Chain Management
Supplying Information
Future Outlook
Community Involvement and Development
Measures to Create Corporate Value
Community Involvement and Development
Policy for Corporate Citizenship Activities
Global Community Involvement
Corporate Foundations
Future Outlook
Policies
Policies
Research
Development
Manufacturing & Quality Assurance
Marketing
Purchasing
The Environment
Corporate Citizenship Activities
Transparency Guideline*
Reports
CSR Data Book Survey
Related Sites
Access to Healthcare